Current status of endocrine treatment of carcinoma of the breast
- 1 January 1990
- journal article
- research article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 6 (2) , 77-82
- https://doi.org/10.1002/ssu.2980060205
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prolonging Tamoxifen Therapy for Primary Breast CancerAnnals of Internal Medicine, 1987
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerBritish Journal of Cancer, 1986
- Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifenCancer, 1982
- Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifenCancer, 1982
- Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancerCancer, 1981
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataPublished by Elsevier ,1976
- Specific progesterone receptors in human breast cancerSteroids, 1975
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896